Locust Wood Capital Advisers, LLC Baxter International Inc Transaction History

Locust Wood Capital Advisers, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$39.98 - $47.68 $9.73 Million - $11.6 Million	243,408 Added 22.91%	1,305,767 $59.5 Million
Q1 2023 May 05, 2023	BUY	$37.58 - $52.57 $39.9 Million - $55.8 Million	1,062,359 New	1,062,359 $43.1 Million
Q4 2020 Jan 25, 2021	SELL	$75.39 - $82.36 $36.5 Million - $39.8 Million	-483,745 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$78.33 - $90.73 $15.3 Million - $17.7 Million	195,200 Added 67.65%	483,745 $38.9 Million
Q2 2020 Jul 21, 2020	SELL	$78.66 - $94.14 $25.7 Million - $30.8 Million	-327,285 Reduced 53.15%	288,545 $24.8 Million
Q1 2020 May 05, 2020	BUY	$71.57 - $93.3 $29 Million - $37.7 Million	404,550 Added 191.48%	615,830 $50 Million
Q4 2019 Jan 28, 2020	SELL	$76.7 - $88.45 $15.2 Million - $17.5 Million	-198,245 Reduced 48.41%	211,280 $17.7 Million
Q3 2019 Oct 22, 2019	SELL	$81.4 - $89.78 $893,772 - $985,784	-10,980 Reduced 2.61%	409,525 $35.8 Million
Q2 2019 Jul 24, 2019	BUY	$73.44 - $82.41 $15.6 Million - $17.5 Million	211,880 Added 101.56%	420,505 $34.4 Million
Q1 2019 Apr 16, 2019	BUY	$64.48 - $81.31 $13.5 Million - $17 Million	208,625 New	208,625 $17 Million

1,006

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Locust Wood Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Locust Wood Capital Advisers, LLC with notifications on news.